tiprankstipranks
Trending News
More News >
Safety Shot, Inc. (SHOT)
:SHOT
US Market

Safety Shot (SHOT) AI Stock Analysis

Compare
866 Followers

Top Page

SH

Safety Shot

(NASDAQ:SHOT)

Rating:44Neutral
Price Target:
$0.50
▲(61.29%Upside)
The overall stock score is heavily influenced by poor financial performance and challenging valuation metrics. While technical analysis shows some negative signs, the pending Yerbaé acquisition offers a potential positive catalyst that may improve market positioning.

Safety Shot (SHOT) vs. SPDR S&P 500 ETF (SPY)

Safety Shot Business Overview & Revenue Model

Company DescriptionSafety Shot (SHOT) is a company focused on developing and marketing health and wellness products. It operates primarily in the health supplements sector, offering a range of products designed to enhance consumer well-being. The company's core product is a proprietary formula aimed at reducing the negative effects of alcohol consumption, promoting recovery, and maintaining overall health.
How the Company Makes MoneySafety Shot generates revenue through the direct sale of its health supplement products to consumers. The company markets its products via its own e-commerce platform, as well as through partnerships with various retail distributors. Key revenue streams include online sales, retail partnerships, and potential licensing agreements for its proprietary formulas. Strategic collaborations with health and wellness influencers and partnerships with retail chains contribute significantly to its earnings by expanding its market reach and brand visibility.

Safety Shot Financial Statement Overview

Summary
The company is facing severe financial challenges, with negative gross and net profit margins, volatile revenue growth, and operational inefficiencies. The balance sheet shows negative equity and increasing debt, while cash flow is negative, indicating reliance on external funding.
Income Statement
25
Negative
The income statement reveals significant challenges. The gross profit margin is negative, indicating cost of goods sold exceeds revenue. Net profit margin is also negative, as the company continues to incur substantial losses. Revenue growth has been volatile, with a sharp decline in the most recent period. EBIT and EBITDA margins are negative, reflecting operational inefficiencies and high operating expenses.
Balance Sheet
20
Very Negative
The balance sheet shows financial instability, with negative stockholders' equity suggesting liabilities exceed assets. Debt-to-equity ratio cannot be calculated due to negative equity, and the company has been increasing its debt load. Return on equity is negative due to sustained losses. The equity ratio is also negative, highlighting a precarious financial position.
Cash Flow
30
Negative
Cash flow analysis indicates severe cash flow issues. Operating cash flow is negative, and free cash flow is in decline, showing the company's difficulties in generating cash from operations. The free cash flow to net income ratio is not meaningful due to negative values. Financing cash flow is positive, suggesting reliance on external funding to cover cash shortfalls.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
701.97K202.67K6.20M2.88M1.07M
Gross Profit
-2.45M-74.46K1.03M535.49K441.10K
EBIT
-42.06M-12.18M-11.49M-16.77M-5.14M
EBITDA
-47.81M-12.19M-15.29M-26.18M-6.01M
Net Income Common Stockholders
-49.41M-15.08M-15.22M-28.10M-6.29M
Balance SheetCash, Cash Equivalents and Short-Term Investments
631.54K5.33M4.85M14.66M4.26M
Total Assets
7.34M12.71M8.69M18.87M6.53M
Total Debt
5.63M2.07M2.73M861.61K1.33M
Net Debt
5.28M-1.76M800.29K-10.89M-2.93M
Total Liabilities
9.51M3.89M5.03M2.27M2.13M
Stockholders Equity
-2.17M8.82M3.67M16.60M4.39M
Cash FlowFree Cash Flow
-19.17M-10.22M-6.41M-7.81M-2.78M
Operating Cash Flow
-19.09M-10.11M-6.40M-7.57M-2.73M
Investing Cash Flow
-4.94K-330.05K-2.47M-13.15M-245.99K
Financing Cash Flow
15.61M12.80M-955.56K28.21M6.71M

Safety Shot Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.31
Price Trends
50DMA
0.39
Negative
100DMA
0.43
Negative
200DMA
0.70
Negative
Market Momentum
MACD
-0.03
Negative
RSI
47.93
Neutral
STOCH
46.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SHOT, the sentiment is Positive. The current price of 0.31 is above the 20-day moving average (MA) of 0.29, below the 50-day MA of 0.39, and below the 200-day MA of 0.70, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 47.93 is Neutral, neither overbought nor oversold. The STOCH value of 46.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SHOT.

Safety Shot Risk Analysis

Safety Shot disclosed 46 risk factors in its most recent earnings report. Safety Shot reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Safety Shot Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$3.56B12.6723.07%4.07%13.22%11.37%
76
Outperform
$1.99B34.5024.86%8.01%11.26%
54
Neutral
$233.80M-28.87%-6.83%19.09%
53
Neutral
$5.22B3.33-44.36%7.55%16.78%-0.12%
53
Neutral
$377.99M-85.68%4.56%57.03%
44
Neutral
$23.81M-1514.12%-61.03%5.63%
39
Underperform
$41.87M-117.82%22.04%-21.72%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SHOT
Safety Shot
0.31
-0.83
-72.81%
AKO.A
Embotelladora Andina SA
20.16
7.09
54.25%
BRFH
Barfresh Food Group
2.63
-0.48
-15.43%
OTLY
Oatly Group
12.99
-6.06
-31.81%
ZVIA
Zevia PBC
3.10
2.40
342.86%
COCO
Vita Coco Company
35.12
7.65
27.85%

Safety Shot Corporate Events

M&A TransactionsBusiness Operations and Strategy
Safety Shot Nears Completion of Yerbaé Acquisition
Positive
Jun 20, 2025

On June 20, 2025, Safety Shot, Inc. announced an update on the expected closing of its acquisition of Yerbaé Brands Corp., a plant-based functional beverage company. Following stockholder approval on June 12, 2025, the final administrative steps are being completed, with the closing now anticipated next week. This acquisition is expected to enhance Safety Shot’s market positioning by integrating Yerbaé’s zero-sugar, zero-calorie energy beverages into its portfolio, appealing to health-conscious consumers.

Private Placements and FinancingShareholder MeetingsStock SplitBusiness Operations and Strategy
Safety Shot Shareholders Approve Key Proposals
Neutral
Jun 16, 2025

On June 12, 2025, Safety Shot, Inc. held a special meeting where shareholders approved several key proposals, including an amendment to the 2024 Equity Incentive Plan to increase the number of shares by up to 22,000,000. Additionally, shareholders authorized the issuance of shares to Yerbaé Shareholders and Core 4 Capital Corp., as well as the issuance of promissory notes and a potential reverse stock split. These decisions reflect strategic moves to enhance the company’s financial flexibility and align with Nasdaq listing requirements, potentially impacting its market positioning and stakeholder interests.

M&A TransactionsShareholder Meetings
Safety Shot Shareholders Approve Yerbaé Acquisition
Positive
Jun 13, 2025

On June 13, 2025, Safety Shot, Inc. announced that its shareholders have approved the acquisition of Yerbaé Brands Corp., a plant-based functional beverage company. The merger, expected to finalize next week, will see the combined entity continue under the Safety Shot name with its stock trading on Nasdaq. This strategic acquisition aims to leverage Yerbaé’s distribution network to enhance growth in the functional beverage market, combining Safety Shot’s wellness products with Yerbaé’s energy beverages.

Private Placements and FinancingLegal Proceedings
Safety Shot Amends Settlement Agreement with Silverback
Neutral
Jun 4, 2025

Safety Shot, Inc., a Delaware corporation, has entered into a liabilities settlement program with Silverback Capital Corporation to manage its debts by issuing freely trading securities. On May 20, 2025, court approval was granted for this program, and on May 29, 2025, the company amended the settlement agreement to adjust terms such as the closing price, valuation period, and minimum price floor, while also issuing 1,000,000 shares to SCC as consideration for legal and transaction fees.

Product-Related AnnouncementsBusiness Operations and Strategy
Safety Shot Expands into Nootropics and Sleep Aid Markets
Positive
Jun 3, 2025

On June 3, 2025, Safety Shot, Inc. announced the initiation of research and development for new product lines targeting the nootropics and sleep aid markets. This strategic expansion leverages the company’s expertise from its Sure Shot™ product to create innovative solutions aimed at cognitive enhancement and restorative sleep. The development phase is underway, with prototypes expected later this year, positioning Safety Shot to potentially gain substantial market share in these rapidly growing sectors.

Shareholder MeetingsStock Split
Safety Shot Announces Virtual Annual Shareholders’ Meeting
Neutral
May 29, 2025

On May 29, 2025, Safety Shot, Inc. announced its upcoming virtual Annual Shareholders’ Meeting scheduled for June 12, 2025. Shareholders are encouraged to vote on several proposals, including share issuance, an incentive plan amendment, and a reverse stock split, which could impact the company’s market strategy and compliance with Nasdaq rules.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Expands Reach with Yerbaé Partnership
Positive
May 28, 2025

On May 27, 2025, Safety Shot, Inc. announced that its acquisition partner, Yerbaé Brands Corp., has entered into a strategic partnership with Guckenheimer, a national food service operator. This collaboration will expand Yerbaé’s distribution of functional beverages across Guckenheimer’s 480 locations in 34 states, enhancing its presence in corporate dining and potentially broadening Safety Shot’s reach in the food and beverage sector.

Private Placements and FinancingLegal Proceedings
Safety Shot’s Liabilities Settlement Program Approved
Neutral
May 27, 2025

Safety Shot has entered into a liabilities settlement program with Silverback Capital Corporation, allowing it to pay down its debts by issuing freely trading securities. The program, which was subject to court approval, received the necessary approval on May 20, 2025, potentially impacting the company’s financial stability and stakeholder interests.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Acquires Yerbae Brands to Boost Revenue
Positive
May 23, 2025

On May 23, 2025, Safety Shot, Inc. announced its acquisition of Yerbae Brands Corp., aiming to leverage Yerbae’s strong retail presence and distributor network to significantly boost its market position and revenue. The acquisition is expected to increase Safety Shot’s annual revenue by 1000% over 2024, enhancing shareholder value and expanding the company’s reach in the functional beverage market.

Private Placements and Financing
Safety Shot Secures Funding Through Share Sale Agreement
Positive
May 15, 2025

On May 9, 2025, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 641,000 shares, generating gross proceeds of $250,000 at a price of $0.39 per share. This transaction reflects Safety Shot’s efforts to secure additional funding, potentially impacting its financial stability and market positioning.

Private Placements and FinancingRegulatory Filings and Compliance
Safety Shot Enters Exchange Agreement with Core 4 Capital
Neutral
May 7, 2025

On May 2, 2025, Safety Shot, Inc. entered into an Exchange Agreement with Core 4 Capital Corp., involving the exchange of common stock and warrants for Series A Preferred Stock. This agreement includes lock-up provisions preventing Core 4 from transferring the shares for at least six months. The company also filed a Certificate of Designation for the Series A Preferred Stock, detailing rights such as dividends, voting rights, and conversion options, which may impact the company’s equity structure and shareholder dynamics.

Product-Related AnnouncementsM&A TransactionsBusiness Operations and Strategy
Safety Shot Expands Distribution and Plans Spin-Off
Positive
Mar 31, 2025

Safety Shot, Inc. announced significant achievements and future plans as it concludes a transformative year. The company experienced successful launches of its Sure Shot product on Amazon and its e-commerce site, both selling out quickly, indicating high demand. Clinical trials have validated the efficacy of Sure Shot in reducing alcohol’s negative effects, bolstering the company’s market position. Safety Shot is expanding its distribution through partnerships with major retailers and plans a spin-off of its Caring Brands division to unlock shareholder value. The company is also acquiring Yerbae to diversify its product offerings and enhance distribution channels. As part of its strategy, Safety Shot is shifting its marketing focus from influencer-centric campaigns to grassroots and partner-based initiatives to improve revenue alignment.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.